Welcome to our dedicated page for American Oncology Network news (Ticker: AONC), a resource for investors and traders seeking the latest updates and insights on American Oncology Network stock.
American Oncology Network Inc (AONC) generates news through practice partnerships, geographic expansion, and clinical research activities. The company's business development announcements reveal its strategy for building a national network of community-based cancer care providers while maintaining physician-led governance.
News coverage for American Oncology Network typically includes partnership announcements with independent oncology and hematology practices joining the network. These affiliation deals expand the company's geographic footprint and add specialized capabilities across different cancer care markets. The network's expansion strategy focuses on preserving local practice identity while integrating operational infrastructure.
Clinical research developments represent another significant news category, as the network presents findings at major oncology conferences and announces participation in multi-site clinical trials. These research activities demonstrate the company's ability to bring investigational therapies to community settings and contribute to cancer treatment evidence.
Regulatory developments, laboratory accreditation milestones, and leadership appointments also generate newsworthy updates. The network's central laboratory services require ongoing certification and compliance oversight, while executive team changes reflect the organization's growth trajectory and strategic priorities.
Track American Oncology Network news to monitor how the physician-led oncology network model evolves in response to healthcare consolidation trends, reimbursement policy changes, and advances in precision medicine that require sophisticated diagnostic and treatment capabilities in community settings.
Florida Oncology and Hematology, a partner practice of American Oncology Network (AON), has relocated its Fort Myers clinic to 14551 Hope Center Loop. The new state-of-the-art facility features 12 exam rooms, nearly 30 infusion chairs, and an onsite lab.
The expanded clinic provides enhanced services including private exam rooms for patient-physician consultations, infusion services, in-house lab and pathology services, and an onsite specialty pharmacy for oral oncolytics. Board-certified medical oncologists Dr. Magali Van den Bergh, Dr. Venkata Parsa, and Dr. Shivtaj Mann are accepting patients at the new location.
The practice serves patients in Cape Coral, Clearwater, Fort Myers, Naples, and surrounding areas across five clinic locations, offering community-based, affordable cancer care in a comfortable environment with state-of-the-art treatments.
American Oncology Network (AON) has appointed Charlie Goddard as General Counsel. Goddard brings over 15 years of legal experience in healthcare law, corporate governance, and compliance, with expertise in fraud and abuse prevention, data privacy, cyber security, dispute resolution, and high-stakes commercial transactions.
Prior to joining AON, Goddard worked at an AmLaw 100 firm and served as general counsel for a leading orthopedic surgery group. He is a graduate of Florida State University College of Law and is licensed to practice in Florida state courts and the U.S. District Court for the Middle District of Florida.
AON's CEO Todd Schonherz and Chief Medical Officer Dr. Stephen Divers expressed confidence that Goddard's healthcare expertise will help navigate complexities while advancing strategic initiatives as the company continues its growth as one of the nation's fastest-growing community oncology networks.
Fort Wayne Medical Oncology and Hematology (FWMOH), established in 1977, has joined the American Oncology Network (AON), a rapidly growing network of community-based oncology practices.
This partnership will enable FWMOH to expand its patient-focused services and continue providing high-quality, compassionate care. Dr. Praveen Kollipara, president of FWMOH, highlighted that this collaboration comes at an exciting time as FWMOH has recently added leading gynecologic oncologists and expanded its presence in Peru and Warsaw.
FWMOH operates nine locations across northeastern Indiana with 16 Board-certified medical oncologists and two Board-certified gynecologic oncologists, Dr. Iwona Podzielinski and Dr. Scott Goodrich. Dr. Podzielinski emphasized that this partnership will strengthen their ability to offer cutting-edge treatments while maintaining a patient-centered approach.
FWMOH provides comprehensive cancer care services, including laboratory services, PET/CT imaging, oral and IV infusion treatments, clinical trials, survivorship programs, and patient support. The clinics feature private exam rooms and on-site infusion suites for patient comfort.
AON’s CEO, Todd Schonherz, and CMO, Stephen Fred Divers, MD, expressed their excitement about the partnership, noting the alignment with AON’s mission to expand access to high-quality, patient-first cancer care nationwide.
Cancer and Blood Specialists of Arizona (CBSA), a partner practice of American Oncology Network (AONC), announces the addition of Dr. Ronak Rakesh Shah to its physician care team at the Casa Grande clinic. Dr. Shah, a Board-certified medical oncologist and hematologist, brings expertise from his education at Michigan State University and fellowship training at Larkin Community Hospital.
CBSA's team now comprises two medical oncologists, a radiation oncologist, a general surgeon, and three advanced practice providers across two Arizona locations. The practice offers comprehensive cancer care services including diagnosis, treatment, clinical trials, survivorship, and patient support, all accessible locally to minimize patient travel.
American Oncology Network (AON) has partnered with Vantage Health Technologies to enhance cancer care delivery through an AI-enabled value-based care platform. The collaboration will initially implement Vantage's SocialHealth360 solution to improve patient navigation and address Social Determinants of Health (SDoH). The platform is expected to save healthcare professionals 5-8 hours weekly on administrative tasks, reduce provider burnout, and improve patient outcomes while lowering care costs. Future phases will focus on implementing AI solutions for value-based care use-cases.
Florida Oncology and Hematology, a partner practice of American Oncology Network (AON) (OTCQX: AONC), has opened a new location in Cape Coral, Florida. The clinic, located at 326 Del Prado Blvd, Suite 301, welcomes three board-certified medical oncologists: Dr. Magali Van den Bergh (Medical Director), Dr. Venkata Parsa, and Dr. Shivtaj Mann.
The new facility offers comprehensive cancer care services, including an on-site infusion room, in-house lab and pathology services, access to an in-house specialty pharmacy, and support with care coordination and financial counseling. This expansion marks Florida Oncology and Hematology's fifth location in Florida since August 2024, demonstrating the practice's commitment to providing community-based, patient-centered oncology care.
American Oncology Network (OTCQX: AONC), a rapidly expanding community-based oncology practice, has announced its plans to release second quarter 2024 financial results on Wednesday, August 14, 2024, before the market opens. The company will host a conference call and live webcast for investors at 8:30 a.m. Eastern Time on the same day.
To join the call, participants can dial 1-877-704-4453 (US) or 1-201-389-0920 (international) using the passcode 13748211. A replay will be available for one week, accessible by dialing 1-844-512-2921 (US) or 1-412-317-6671 (international) with the Access ID 13748211. The financial results and live webcast will also be available on the company's Investor Relations website at investors.aoncology.com.
American Oncology Network (AON) announced its transition from NASDAQ to the OTCQX Best Market, trading under the symbol AONC. The move aims to enhance transparency and convenience for U.S. investors, brokers, and institutions. CEO Todd Schonherz highlighted the benefits of OTCQX, including adherence to high financial standards and improved trading experiences. Shares and warrants began trading on June 10, 2024, with warrants being listed on OTCQB as AONCW. The company aims to expand its network of oncology practices, offering affordable cancer care nationwide. Financial disclosures and real-time quotes are available on otcmarkets.com.
American Oncology Network (AON) (Nasdaq: AONC) has appointed David Afshar as Chief Financial and Operating Officer. Afshar brings over 25 years of experience in healthcare services, focusing on high-growth environments. His expertise spans M&A, capital markets, and IPOs. CEO Todd Schonherz and CMO Stephen 'Fred' Divers welcomed Afshar, highlighting his potential to drive AON's financial and operational strategies. Afshar aims to enhance accessibility and affordability in cancer care, leveraging his collaborative approach. Previously, Afshar served as CFO for U.S. Heart and Vascular, Aveanna Healthcare, and ApolloMD.
American Oncology Network (AON) announced its decision to delist its Class A common stock and warrants from Nasdaq, effective around June 7, 2024. This decision, recommended by a Special Committee of independent directors, aims to address issues such as the lack of research coverage, an inactive trading market, and high regulatory costs associated with Nasdaq listing. AON will file Form 25 with the SEC on or about May 31, 2024. The company plans to transition its securities to trading on the OTC Markets Group. CEO Todd Schonherz highlighted AON's financial health, boasting over $100 million in cash and a 42% revenue CAGR over the past five years.
FAQ
What is the current stock price of American Oncology Network (AONC)?
What is the market cap of American Oncology Network (AONC)?
